Long-term expression of protein kinase C in adult mouse hearts improves postischemic recovery.

Activation of protein kinase C (PKC) protects the heart from ischemic injury; however, its mechanism of action is unknown, in part because no model for chronic activation of PKC has been available. To test whether chronic, mild elevation of PKC activity in adult mouse hearts results in myocardial protection during ischemia or reperfusion, hearts isolated from transgenic mice expressing a low level of activated PKCbeta throughout adulthood (beta-Tx) were compared with control hearts before ischemia, during 12 or 28 min of no-flow ischemia, and during reperfusion. Left-ventricular-developed pressure in isolated isovolumic hearts, normalized to heart weight, was similar in the two groups at baseline. However, recovery of contractile function was markedly improved in beta-Tx hearts after either 12 (97 +/- 3% vs. 69 +/- 4%) or 28 min of ischemia (76 +/- 8% vs. 48 +/- 3%). Chelerythrine, a PKC inhibitor, abolished the difference between the two groups, indicating that the beneficial effect was PKC-mediated. (31)P NMR spectroscopy was used to test whether modification of intracellular pH and/or preservation of high-energy phosphate levels during ischemia contributed to the cardioprotection in beta-Tx hearts. No difference in intracellular pH or high-energy phosphate levels was found between the beta-Tx and control hearts at baseline or during ischemia. Thus, long-term modest increase in PKC activity in adult mouse hearts did not alter baseline function but did lead to improved postischemic recovery. Furthermore, our results suggest that mechanisms other than reduced acidification and preservation of high-energy phosphate levels during ischemia contribute to the improved recovery.

[1]  G. King,et al.  In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. , 1998, The Journal of clinical investigation.

[2]  Y. Ladilov,et al.  Protection of rat cardiomyocytes against simulated ischemia and reoxygenation by treatment with protein kinase C activator. , 1998, Circulation research.

[3]  G. Fishman,et al.  Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. , 1997, The Journal of clinical investigation.

[4]  P. Ping,et al.  Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. , 1997, Circulation research.

[5]  G. King,et al.  Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Miyawaki,et al.  Ca2+ as a mediator of ischemic preconditioning. , 1997, Circulation research.

[7]  K. Ytrehus,et al.  Endothelin-1 can reduce infarct size through protein kinase C and KATP channels in the isolated rat heart. , 1996, Cardiovascular research.

[8]  W. Wetsel,et al.  Effect of ischemic preconditioning and PKC activation on acidification during ischemia in rat heart. , 1996, Journal of molecular and cellular cardiology.

[9]  J. Downey,et al.  Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease. , 1996, Annual review of medicine.

[10]  L. Edmunds,et al.  Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension. , 1995, Circulation.

[11]  J. Downey,et al.  Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. , 1995, Journal of molecular and cellular cardiology.

[12]  A. Harken,et al.  Preconditioning of isolated rat heart is mediated by protein kinase C. , 1995, Circulation research.

[13]  S. Steinberg,et al.  Protein kinase C isoform diversity in the heart. , 1995, Journal of molecular and cellular cardiology.

[14]  F. Eberli,et al.  Effects of brief repetitive ischemia on contractility, relaxation, and coronary flow. Exaggerated postischemic diastolic dysfunction in pressure-overload hypertrophy. , 1993, Circulation research.

[15]  R. Sievers,et al.  Loss of Myocardial Protection After Preconditioning Correlates With the Time Course of Glycogen Recovery Within the Preconditioned Segment , 1993, Circulation.

[16]  R. London,et al.  Mechanism of preconditioning. Ionic alterations. , 1993, Circulation research.

[17]  J. Watson,et al.  Concentration-dependent effects of protein kinase C-activating and -nonactivating phorbol esters on myocardial contractility, coronary resistance, energy metabolism, prostacyclin synthesis, and ultrastructure in isolated rat hearts. Effects of amiloride. , 1991, Circulation research.

[18]  R. Jennings,et al.  Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. , 1990, Circulation research.

[19]  L. Wexler,et al.  Enhanced Sensitivity to Hypoxia‐Induced Diastolic Dysfunction in Pressure‐Overload Left Ventricular Hypertrophy in the Rat: Role of High‐Energy Phosphate Depletion , 1988, Circulation research.

[20]  P. Polimeni,et al.  Expansion of extracellular tracer spaces in the isolated heart perfused with crystalloid solutions: expansion of extracellular space, trans-sarcolemmal leakage, or both? , 1988, Journal of molecular and cellular cardiology.